Australia’s industrial and logistics sector has propelled the commercial real estate market in the first half of 2025, while the office sector has lagged, according to a recent report, which also found a spike in offshore investments.
US biotech company Regeneron Pharmaceuticals has sued Sandoz, claiming it is threatening to infringe the patent for its Eylea biologic, used to treat macular degeneration and diabetic macular oedema.
The corporate regulator has secured travel restrictions and freezing orders against two directors of Falcon Capital as part of its investigation into its managed investment fund.
The owner of Banana Boat and Hawaiian Tropic sunscreen brands faces court action by the consumer regulator for alleged greenwashing.
A luxury Aqualand development in Milsons Point can’t undo a $10.6 million freezing order granted to the owners corporation to address the risk that funds would be unavailable to meet its claim for damages to remedy alleged defects.
Lendlease has filed an appeal after it failed in its bid to enforce a $120 million purchase agreement for five plots of land in Campbelltown, in a high-stakes challenge set to be heard later this year.
Fund manager Realside and other leaseholders have launched proceedings against M3Property and a valuer, alleging tenants of Rundle Mall in Adelaide have been overcharged for rent since 2006 as a result of consistently flawed valuations.
Lendlease’s $500 million residential project in Sydney’s eastern suburbs known as One Darling Point has secured development approval from the NSW government in just five months.
US private equity firm KKR will acquire agriculture infrastructure firm ProTen from superfund Aware Super, in a deal valued at around $1.3 billion.
Two Shaw & Partners advisers who won $580,000 in penalties and compensation against former employer Fortrend Securities face fresh litigation seeking to quash their demands for payment.